Chemed Corp (CHE) Peer Comparison
$514.30
$2.14
(0.42%)
As on 28-Sep-2026 16:00EDT
Market cap
$6,588 Mln
Revenue (TTM)
$2,595 Mln
P/E Ratio
25.4
P/B Ratio
8
Div. Yield
0.5 %
Edit
| Chemed Corp (CHE) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Hims Hers Health Inc (HIMS) | RadNet (RDNT) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
6,588 | 12,011 | 10,210 | 6,507 | 5,571 |
Revenue ($ Mln) |
2,595 | 6,206 | 5,487 | 2,578 | 2,269 |
Net Profit ($ Mln) |
274.99 | 621.00 | 378.70 | -142.03 | -21.12 |
Net Margin (%) |
10.60 | 10.01 | 6.90 | -5.51 | -0.93 |
RoE (%) |
30.39 | 16.23 | 16.18 | -32.84 | -5.63 |
Price to Earnings |
25.36 | 20.36 | 27.46 | -- | -- |
Price-To-Book |
7.96 | 4.68 | 4.18 | 20.16 | 5.31 |
Income Statement ($ Mln)
| Chemed Corp (CHE) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Hims Hers Health Inc (HIMS) | RadNet (RDNT) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
2,595.00 | 6,206.10 | 5,486.71 | 2,578.11 | 2,268.93 |
|
Cost of Revenue
|
1,805.04 | 1,733.50 | 4,710.80 | 910.53 | 2,048.83 |
|
Gross Profit
|
758.34 | 5,680.80 | 799.45 | 1,733.38 | 90.80 |
|
Operating Expenses
|
440.80 | 3,421.70 | 308.52 | 1,760.25 | 176.07 |
|
Operating Profit (EBIT)
|
349.19 | 1,117.00 | 467.39 | -92.67 | 90.84 |
|
Other Income
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
369.16 | 1,027.90 | 498.93 | -163.61 | 34.98 |
|
Provision for Tax
|
94.17 | 210.30 | 119.90 | -21.58 | 15.71 |
|
Profit after Tax (Net Income)
|
274.99 | 621.00 | 378.70 | -142.03 | -21.12 |
|
Minority Interest
|
0.00 | -212.30 | -0.33 | 0.00 | -40.39 |
|
Consolidated Profit
|
140.99 | 271.90 | 0.00 | 0.00 | 0.00 |
Liabilities ($ Mln)
| Chemed Corp (CHE) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Hims Hers Health Inc (HIMS) | RadNet (RDNT) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
830.51 | 2,597.70 | 2,441.69 | 324.07 | 1,096.09 |
|
Minority Interest
|
0.00 | -212.30 | -0.33 | 0.00 | -40.39 |
|
Non-Current Liabilities
|
429.23 | 3,123.00 | 2,419.29 | 1,821.51 | 2,134.48 |
|
Current Liabilities
|
319.85 | 873.40 | 884.80 | 1,483.23 | 697.82 |
|
Total Liabilities
|
1,640.01 | 7,089.70 | 5,462.97 | 2,154.71 | 3,758.56 |
Assets ($ Mln)
| Chemed Corp (CHE) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Hims Hers Health Inc (HIMS) | RadNet (RDNT) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
1,288.35 | 6,416.50 | 4,677.91 | 2,244.20 | 3,190.60 |
|
Current Assets
|
291.24 | 1,041.00 | 1,071.49 | 1,384.61 | 1,035.76 |
|
Total Assets
|
1,640.01 | 7,089.70 | 5,462.97 | 2,154.71 | 3,758.56 |
|
Total Debt*
|
329.09 | 2,842.30 | 2,250.35 | 1,546.24 | 2,182.71 |
|
Net Current Assets
|
0.00 | 167.60 | 186.69 | -98.62 | 337.93 |
Cashflow ($ Mln)
| Chemed Corp (CHE) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Hims Hers Health Inc (HIMS) | RadNet (RDNT) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
388.27 | 1,175.60 | 564.27 | 300.01 | 298.82 |
|
Cash Flow from Investing Activities
|
-59.34 | -762.80 | -513.18 | -1,024.96 | -343.87 |
|
Cash from Financing Activities
|
-432.77 | -433.00 | -11.81 | 729.62 | 72.21 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Chemed Corp (CHE) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Hims Hers Health Inc (HIMS) | RadNet (RDNT) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
22.16 | 11.40 | 6.75 | 11.94 | -0.67 |
|
ROE (%)
|
30.39 | 16.23 | 16.18 | -32.84 | -5.63 |
|
ROA (%)
|
14.28 | 7.77 | 6.15 | -3.91 | -0.47 |
|
EBIT Margin (%)
|
14.08 | 18.59 | 9.24 | -6.35 | 4.68 |
|
Net Margin (%)
|
10.60 | 10.01 | 6.90 | -5.51 | -0.93 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Chemed Corp (CHE) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Hims Hers Health Inc (HIMS) | RadNet (RDNT) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
3.31 | 9.47 | 18.89 | 28.04 | 18.92 |
|
EBIT Growth (%)
|
-6.25 | 16.43 | 17.37 | -217.51 | 16.93 |
|
Net Profit Growth (%)
|
-5.29 | 18.81 | 17.32 | -173.36 | -41.55 |
|
EPS Growth (%)
|
1.50 | 20.05 | 15.72 | -179.07 | -36.16 |
|
Book Value Growth (%)
|
-24.60 | 16.44 | 19.22 | -36.19 | 10.61 |
Valuation Ratios
| Chemed Corp (CHE) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Hims Hers Health Inc (HIMS) | RadNet (RDNT) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
22.57 | 19.12 | 30.03 | 62.76 | -287.63 |
|
Price / Book Value
|
6.11 | 4.44 | 4.63 | 14.89 | 4.92 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
14.37 | 9.54 | 24.49 | 48.19 | 25.42 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Chemed Corp (CHE) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Hims Hers Health Inc (HIMS) | RadNet (RDNT) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 1.00 | 0.06 | 4.21 | 1.19 |
|
Short term debt to equity ratio
|
0.09 | 0.02 | 0.05 | 0.04 | 0.09 |
|
Current Ratio
|
0.91 | 1.19 | 1.21 | 0.93 | 1.48 |
|
Quick Ratio
|
0.89 | 1.19 | 1.21 | 0.87 | 1.48 |
|
Interest Coverage
|
77.54 | 9.18 | 65.04 | -- | 1.49 |
Operating Efficiency Ratios
| Chemed Corp (CHE) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Hims Hers Health Inc (HIMS) | RadNet (RDNT) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
7.27 | 11.07 | 12.19 | 14.56 | 10.66 |
|
Asset Turnover
|
1.35 | 0.78 | 0.89 | 0.71 | 0.51 |
|
Receivable days
|
25.53 | 37.48 | 43.58 | 2.97 | 39.44 |
|
Inventory Days
|
1.62 | -- | -- | 53.56 | -- |
|
Payable days
|
10.06 | 250.68 | 8.42 | 69.71 | 23.39 |
|
Cash Conversion Cycle
|
17.10 | -- | -- | -13.17 | -- |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
